![]() |
市場調查報告書
商品編碼
964876
亞太地區的病患監測市場-成長,趨勢,及預測(2020年∼2025年)Asia-Pacific Patient Monitoring Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027) |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
由於慢性病患者的數量增加以及對家庭和遠程監護的偏愛之類的因素,預計亞太地區患者監護市場規模將在預測期內創下較高的複合年增長率。
本報告提供亞太地區的病患監測電市場調查,提供市場概要,市場成長要素及阻礙因素分析,各類型·各地區的市場規模的變化與預測,競爭情形,主要企業的簡介,市場機會等全面性資訊。
The Asia-Pacific Patient Monitoring Market is expected to register a CAGR of 6.6% during the forecast period, owing to the factors such as the increasing burden of chronic disorders and growing preference for home and remote monitoring.
Cardiovascular diseases are one the leading cause of increased morbidity and mortality in Asia-Pacific. There are an estimated number of 1.2 million (5.6%) Australian adults aged 18 years and over had 1 or more conditions related to the heart or vascular disease, including stroke, in 2017-18, based on self-reported data from the the Australian Institute of Health and Welfare (AIHW) National Hospital Morbidity Database. Therefore the growing burden of such diseases is expected to increase the demand for monitoring systems in the market during the forecast period.
The adoption of sedentary lifestyle in Asian people, such as physcial inactivity, poor diet, high consumption of sugar,etc. has led to many of the chronic conditions such as diabetes, obesity, cardiovascular diseases and others. China and India has the highest diabetic population compare to other countries. Furthermore, the burden is expected to continue to increase over the period.
According to the International Diabetes Federation, in 2020, around 77,005,600 cases were registered in India for Diabetes that constitutes about 8.9% of the total population. Similarly, according to the Australian Institute of Health and Welfare, 2017-18, around 67% adults aged 18 years and above were overweight and around 25% children aged between 2 years and 17 years were overweight in Australia. Hence, it has become essential to manage these patients overall health and therefore, these factors are expected to increase the demand for weight management & fitness monitoring.
The Asia-Pacific Patient Monitoring Market is fragmented. The market players in the Asia-Pacific Patient Monitoring Market are Koninklijke Philips N.V., GE Healthcare, BPL Group, Mindray Medical International Co. Ltd., Nihon Kohden Corporation, Dragerwerk AG, Siemens Healthcare GmBH, Masimo, Schiller and Spacelabs Healthcare. In 2019, Mindray Medical International Co. Ltd., introduced " BeneHeart C Series " for monitoring the heart rate.